Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 696,560Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Novartis Pharmaceuticals Australia Pty Limited

02 1Novartis Pharmaceuticals Corporation

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

BioJapan
Not Confirmed
arrow
arrow
BioJapan
Not Confirmed

INCLISIRAN SODIUM

Brand Name : LEQVIO

Dosage Form : SOLUTION;SUBCUTANEOUS

Dosage Strength : EQ 284MG BASE/1.5ML (EQ 189MG BASE/ML)

Packaging :

Approval Date : 2021-12-22

Application Number : 214012

Regulatory Info : RX

Registration Country : USA

blank

02

Novartis Pharmaceuticals Australia ...

Country
BioJapan
Not Confirmed
arrow

Novartis Pharmaceuticals Australia ...

Country
arrow
BioJapan
Not Confirmed

inclisiran

Brand Name : Leqvio

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank

03

Novartis Pharmaceuticals Australia ...

Country
BioJapan
Not Confirmed
arrow

Novartis Pharmaceuticals Australia ...

Country
arrow
BioJapan
Not Confirmed

inclisiran

Brand Name : Leqvio

Dosage Form :

Dosage Strength :

Packaging : 1

Approval Date :

Application Number :

Regulatory Info :

Registration Country : Australia

blank